Clinical trial
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
NCT00315081 · University Hospital, Bonn, Other · Unknown status
Key facts
| NCT number | NCT00315081 |
|---|---|
| Title | Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine |
| Official title | Therapy With Bromocriptine in Patients With Symptomatic Risperidone-Induced Hyperprolactinemia |
| Lead sponsor | University Hospital, Bonn, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Hyperprolactinemia |
| Intervention type | Drug |
| Interventions | Bromocriptin |
| Enrollment | 20 |
| Start date | May 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Apr 17, 2006 |
| Last update posted | Apr 17, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: